Publications:

Case report: Radiotherapy plus pneumococcal conjugate vaccine stimulates abscopal immune response in a patient with ALK+ NSCLC.

Frontiers In Immunology

Huang, Yong-Sheng YS; Li, Zhuo Z; Xiao, Ze-Fen ZF; Li, Dan D; Liu, Wen-Yang WY

Publication Date: 2022

Variant appearance in text: ALK: P1094H

PubMed Link: 36032102

Variant Present in the following documents:

• fimmu-13-950252.pdf

View BVdb publication page

Multiple Genetic Alterations as Resistance Mechanism during Second-Line Lorlatinib for Advanced ALK-Rearranged Lung Adenocarcinoma: A Case Report.

Diagnostics (Basel, Switzerland)

Catino, Annamaria A; Lacalamita, Rosanna R; De Summa, Simona S; Pesola, Francesco F; Tommasi, Stefania S; Galetta, Domenico D

Publication Date: 2022-03-11

Variant appearance in text: ALK: P1094H

PubMed Link: 35328235

Variant Present in the following documents:

• diagnostics-12-00682.pdf

View BVdb publication page

Utility of the Ba/F3 cell system for exploring on-target mechanisms of resistance to targeted therapies for lung cancer.

Cancer Science

Koga, Takamasa T; Suda, Kenichi K; Mitsudomi, Tetsuya T

Publication Date: 2022-03

Variant appearance in text: ALK: P1094H

PubMed Link: 34997674

Variant Present in the following documents:

• CAS-113-815.pdf

View BVdb publication page